 Featured Story
What went right and what went wrong during the COVID-19 pandemic will undoubtedly be studied for decades to come. And one resource that scholars and students will likely turn to is the recently released COVID-19: Systemic Risk and... |
|
Jul 21, 2021 - Barri Bronston
Tulane researcher Kristin Miller is teaming up with the Tulane spin-out company BioAesthetics Corp. to develop a new graft for treating pelvic organ prolapse (POP).
|
|
Jul 21, 2021 - Keith Brannon
Tulane University School of Medicine and Children’s Hospital New Orleans are participating in a national clinical trial to test the effectiveness of Moderna’s COVID-19 vaccine in children ages six months to 11 years old. |
|
Jul 14, 2021 - Leslie Tate
Key infectious disease researchers at Tulane University, Duke University and North Carolina State University will collaborate on an initiative to develop a treatment for bartonelloses, a spectrum of vector-borne diseases that can cause debilitating symptoms. The three-year, $4.8 million initiative funded by The Steven and Alexandra Cohen Foundation, will establish the Bartonella Research Consortium to develop a novel treatment for bartonelloses. |
|
Jul 12, 2021 - Barri Bronston
Michael J. Moore, a professor of biomedical engineering at Tulane, will lead an NIH group that reviews applications on a wide range of technologies as applied to neural systems and to tissues of the eye. |
|
Jun 30, 2021 - Barri Bronston
Tulane scientist Jennifer Whitten to be part of the leadership team of a mission to Venus later this decade. |